A database of FDA approved therapeutic peptides and proteins
ID1187 | ThPPIDTh1024 | NameGramicidin D | Peptide SequenceVGALAVVVWLWLWLWX Full view | Length16 | Functional ClassificationIIa | DiseaseInfectious | BrandNeosporin | CompanyPfizer | Physical AppearanceOintment | Route of AdministartionExternal use only | CategoryAnti-Bacterial Agents, Anti-infective, Topical, Antibiotic | TargetN.A. |
ID1289 | ThPPIDTh1042 | NameCollagenase | Peptide SequenceMKRKCLSKRLMLAITMATIF Full view | Length255 | Functional ClassificationIc | DiseaseHematological | BrandSantyl | CompanyAdvance Biofactures Corp | Physical AppearanceSterile enzymatic debriding ointment | Route of AdministartionExternal use only | CategoryN.A. | TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain |
ID1454 | ThPPIDTh1084 | NameBecaplermin | Peptide SequenceSLGSLTIAEPAMIAECKTRT Full view | Length109 | Functional ClassificationIb | DiseaseCardiac | BrandREGRANEX | CompanyOMJ Pharmaceuticals, Inc. San German, Puerto Rico | Physical AppearanceGel: 0.01 %; clear, colorless to straw-colored gel | Route of AdministartionExternal use only | CategoryAngiogenesis Inducing Agents | TargetT-cell surface glycoprotein CD1a,Major histocompatibility complex class I-related gene protein,Integrin alpha-L,T-lymphocyte activation antigen CD86,Low affinity immunoglobulin gamma Fc region receptor II-b,T-cell surface glycoprotein CD4,Integrin beta-1,Integrin alpha-V,Integrin beta-3 |